Telcon Rf Pharmaceutical
Manufacturing · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
54 Gongse-ro, Yongin-si Giheung-gu, Gyeo...Website
www.telcon.co.krRevenue
$54.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Telcon Rf Pharmaceutical
텔콘RF제약 specializes in the pharmaceutical and biotechnology sectors, focusing on the development and commercialization of innovative treatments. The company is particularly noted for its involvement in clinical trials for COVID-19 therapies, such as 렌질루맙. Its intended clients include healthcare providers and patients seeking advanced medical solutions. Additionally, 텔콘RF제약 is preparing for its entry into the KOSDAQ market, highlighting its growth and investment potential.Explore more
Popular SearchesTelcon RF PharmaceuticalSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Telcon Rf Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Telcon Rf Pharmaceutical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Telcon Rf Pharmaceutical had a recent Job posting/layoffs
Product Launch: Get notified when Telcon Rf Pharmaceutical launches new products
Check out if Telcon Rf Pharmaceutical is spiking on competitors!
Earning: See what the market has to say on Telcon Rf Pharmaceutical recently announced quarterly report
Funding: Get notified immidiatlly once Telcon Rf Pharmaceutical has new funding data
Website visits: Recent activity has been detected on your website
Telcon Rf Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Telcon Rf Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Telcon Rf Pharmaceutical
Find more new buyers
Company Profile Activity
Activity Insights
Telcon Rf Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Telcon Rf Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Telcon Rf Pharmaceutical.
Telcon Rf Pharmaceutical Tech Stack
A closer look at the technologies used by Telcon Rf Pharmaceutical
See more technologies
Telcon Rf Pharmaceutical News & Media
Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, today announced the execution of its first licensing transaction in the Asia-Pacific Region with Telcon RF Pharmaceutical, Inc. (“Telcon”) (200230.KQ) and KPM Tech Co., Ltd (“KPM Tech”) (042040.KQ) for development and commercialization rights to leEmmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc. Shares
TORRANCE, Calif., Oct. 14, 2020 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, announced today that it has sold all remaining common shares of South Korea-based Telcon RF Pharmaceutical Inc. (KOSDAQ: 200230) in accordance with the Telcon...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Telcon Rf Pharmaceutical
Sign Up For FreeTo access detailed company insights
텔콘RF제약 specializes in the pharmaceutical and biotechnology sectors, focusing on the development and commercialization of innovative treatments. The company is particularly noted for its involvement in clinical trials for COVID-19 therapies, such as 렌질루맙. Its intended clients include healthcare providers and patients seeking advanced medical solutio... Read More
